Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease

Clinical trial NCT02212678 · COMPLETED

Trial details

NCT number: NCT02212678
Sponsor: University of Minnesota
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2014-09-01
Primary completion: 2015-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.